Susumu Kashine

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 612 citations · Full text

Medicine, Endocrinology, Nephrology +10

Matrix Metalloproteinases as Novel Disease Markers in Takayasu Arteritis

Akifumi Matsuyama, Naohiko Sakai, Masato Ishigami et al. · Circulation · 2003 · 166 citations · Full text

Medicine, Pathology, Immunopathology +14

Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease

Zien Zhou, Meg Jardine, Qiang Li et al. · Stroke · 2021 · 118 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Short-term effects of liraglutide on visceral fat adiposity, appetite, and food preference: a pilot study of obese Japanese patients with type 2 diabetes

Kana Inoue, Norikazu Maeda, Susumu Kashine et al. · Cardiovascular Diabetology · 2011 · 86 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Efficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes

Yuya Fujishima, Norikazu Maeda, Kana Inoue et al. · Cardiovascular Diabetology · 2012 · 64 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17